ArticleTransfusion medicine (Oxford, England)2025
Reducing blood component wastage through targeted interventions: A four-year retrospective study at a Saudi tertiary hospital.
Article in Transfusion medicine (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Factors Influencing Blood Component Availability: The Views of Transfusion Service Leaders in Riyadh, Saudi Arabia.Cureus · 2026Article
- Reducing blood product wastage: Insights from a retrospective study in a tertiary health facility.PloS one · 2026Article
- Reducing blood component wastage through targeted interventions: A four-year retrospective study at a Saudi tertiary hospital.Transfusion medicine (Oxford, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood transfusion services are vital to healthcare; however, blood component wastage remains a persistent challenge for transfusion facilities, impacting resource efficiency and patient care. In this four-year retrospective before-and-after study, we investigated blood component wastage at a tertiary hospital in Saudi Arabia to identify key causes of wastage and evaluate the impact of targeted interventions introduced in 2024.
methodsStatistical analyses included z-tests for rate comparisons, effect size estimation using Cohen's h, and 95% confidence intervals (CIs) to assess the impact of the interventions.
resultsFrom 2021 to 2024, 83,185 components were prepared and 13,954 units were discarded. Between 2021 and 2023, the average waste rate was 19.44%. Leading causes included expiration (28.40%), TTI screening reactivity (20.11%), and low platelet yield (18.39%). Following the 2024 implementation of targeted measures-including improved inventory policies, donor screening, and transfusion practices-total waste declined by 35.71% (p < 0.001, 95% CI: 0.016 to 0.024), with a moderate effect size (Cohen's h = 0.20). Total monthly waste rates were also significantly reduced (mean difference of 7.73 percentage points; p < 0.001, 95% CI: 4.87% to 10.59%, Cohen's d = 2.29). The WAPI scores improved across all components, and associated costs were reduced by 15.9%, saving approximately SAR 171366 (US$45856).
conclusionThese findings demonstrate the effectiveness of interventions for reducing blood component wastage and enhancing transfusion service efficiency. Ongoing monitoring and continuous quality improvement are essential to sustain these outcomes and further optimize transfusion practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.